JG
DCPH

Jefferies Group’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Jefferies Group’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-10,900
Closed -$106K – 2031
2021
Q4 		$106K Hold
10,900
– – ﹤0.01% 1468
2021
Q3 		$370K Sell
10,900
-35,000
-76% -$1.12M ﹤0.01% 1326
2021
Q2 		$1.68M Hold
45,900
– – 0.01% 804
2021
Q1 		$2.06M Buy
+45,900
New +$2.14M 0.02% 671

Other funds holding DCPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Jefferies Group's DCPH Position: Q3 2022 in Review

Jefferies Group reduced its Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) stake by 75% in Q3 2022, selling an estimated $8.1M and leaving 175,148 shares worth $3.24M. The position accounts for 0.03% of the portfolio, ranked #458.

Jefferies Group first reported a position in DCPH in Q4 2019 and has held it in 11 quarters since. The position peaked at $9.09M in Q2 2022. 150 funds tracked by Wall St. Rank hold DCPH as of Q3 2022.

  • Jefferies Group held 175,148 shares of Deciphera Pharmaceuticals, Inc. Common Stock worth $3.24M as of Q3 2022.
  • Jefferies Group sold 515,852 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q3 2022, an estimated $8.1M.
  • Deciphera Pharmaceuticals, Inc. Common Stock made up 0.03% of Jefferies Group's portfolio in Q3 2022, its #458 holding.
  • Jefferies Group first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q4 2019 and has held it in 11 quarters since.
  • Jefferies Group's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $9.09M in Q2 2022.
  • 150 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.